Brochure
2 Oct 2024
EVER Pharma - Product List
PDF 145 kB
EVER Pharma's products include:
- Atosiban -- 7.5 mg/ml Solution for Injection/Infusion
- Azacitidine -- 25 mg/ml Powder for Suspension for Injection
- Cabazitaxel -- 10 mg/ml - Solution for Infusion
- Cerebrolysin® -- 215.2 mg/ml - Solution for Infusion Concentrate for Solution for Infusion
- Dacepton (Apomorphine) -- 5 mg/ml & 10 mg/ml - Solution for Injection/Infusion
- Dexmedetomidine -- 100 µg/ml - Concentrate for Solution for Infusion
- Docetaxel -- 20 mg/ml - Concentrate for injection
- Fulvestrant -- 50 mg/ml - Ready to use pre-filled syringe
- Oxytocin -- 5 IU/ml & 10 IU/ml - Solution for Injection/Infusion
- Paclitaxel-- 6 mg/ml - Concentrate for Injection
- Pemetrexed -- 25 mg/ml - Concentrate for Solution for Infusion
- Terlipressin -- 0.17 mg/ml - Solution for Injection/Infusion
Content provided by our supplier
EVER Pharma
-
AT
-
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
Other Content from EVER Pharma (17)
-
News EVER Pharma gains EU Marketing Authorization for Trabectedin
EVER Pharma announces the EU-wide marketing authorization of Trabectedin (in 0.25MG and 1MG vial sizes) for the treatment of advanced soft tissue sarcoma and ovarian cancer -
Technical Data EVER Pharma: Product list of speciality injectables
EVER Pharma's products include: Atosiban -- 7.5 mg/ml Solution for Injection/InfusionAzacitidine -- 25 mg/ml Powder for Suspension for InjectionCabazitaxel -- 10 mg/ml - Solution for InfusionCerebrolysin® -- 215.2 mg/ml - Solution for Infusion Concentrate for Solution for InfusionDacepton (Apomorphine) -- 5 mg/ml & 10 mg/ml - Solution for Injection/InfusionDexmedetomidine -- 100 µg/ml - Concentrate for Solution for InfusionDocetaxel -- 20 mg/ml - Concentrate for injectionFulvestrant -- 50 mg/ml - Ready to use pre-filled syringeOxytocin -- 5 IU/ml & 10 IU/ml - Solution for Injection/InfusionPaclitaxel-- 6 mg/ml - Concentrate for InjectionPemetrexed -- 25 mg/ml - Concentrate for Solution for InfusionTerlipressin -- 0.17 mg/ml - Solution for Injection/Infusion -
News EVER Pharma Expands Operations with Opening of New Manufacturing Facility in Jena, Germany
EVER Pharma Expands Operations with Opening of New Manufacturing Facility in Jena, Germany -
Brochure EVER CDMO: Contract Manufacturing
Contract Manufacturing Overview -
News EVER Pharma Announces Approval of Testosterone Undecanoate in the EU
EVER Pharma has announced the approval of Testosterone Undecanoate in the European Union for the treatment of male hypogonadism. -
Brochure EVER CDMO: Contract Development
Overview on EVER's contract development services -
News EVER Pharma Gained EU-Approval of Testosterone Enantate
EVER Pharma, a fully integrated specialty pharmaceuticals company, is pleased toannounce the approval of Testosterone Enantate in the European Union for thetreatment of male hypogonadism. This condition, characterized by insufficienttestosterone production, affecting up to 10% of men globally and 40% of men aged 45. -
News EVER Pharma gained EU-Approval for Advanced Cancer Treatment
EVER Pharma, a fully integrated specialty pharmaceuticals company, announced the approval of Eribulin in the European Union. Eribulin is indicated for the treatment of locally advanced or metastatic breast cancer and unresectable liposarcoma.
-
Brochure Cabazitaxel EVER Pharma
45mg/4.5ml + 50mg/5.0ml + 60mg/6ml -
News EVER Pharma receives EU approval for a liquid ready to use Bortezomib formulation
EVER Pharma is pleased to announce EU-wide approval of Bortezomib for the treatment of patients with multiple myeloma and mantle cell lymphoma -
Brochure Trabectedin EVER Pharma
0.25mg + 1mg -
Brochure Fulvestrant EVER Pharma
PFS - 250mg/5ml -
Brochure Dexmedetomidine EVER Pharma
Vials + Ampoules: 200µg/2ml + 400µg/4ml + 1000µg/10ml -
Brochure Terlipressin EVER Pharma
1mg/5ml + 2mg/10ml -
Brochure Atosiban EVER Pharma
6.75mg/0.9ml + 37.5/5ml + 75mg/10ml -
Brochure Bortezomib EVER Pharma
2.5mg/1ml + 3.5mg/1.4ml -
Brochure Pemetrexed EVER Pharma
100mg/4ml + 500mg/20ml + 1000mg/40ml
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance